Tower Research Capital LLC (Trc) Immix Biopharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 181 shares of IMMX stock, worth $291. This represents 0.0% of its overall portfolio holdings.
Number of Shares
181
Previous 3,110
94.18%
Holding current value
$291
Previous $4,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IMMX
# of Institutions
28Shares Held
3.3MCall Options Held
11.5KPut Options Held
900-
Bleichroeder LP New York, NY850KShares$1.37 Million0.6% of portfolio
-
Cable Car Capital LLC San Francisco, CA796KShares$1.28 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA699KShares$1.12 Million0.0% of portfolio
-
Lynwood Capital Management Inc.405KShares$652,05011.13% of portfolio
-
Geode Capital Management, LLC Boston, MA150KShares$241,6320.0% of portfolio
About Immix Biopharma, Inc.
- Ticker IMMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,910,100
- Market Cap $22.4M
- Description
- Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...